This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mancuso, M. Articles by Saran, A. Search for Related Content PubMed PubMed Citation Articles by Mancuso, M. Articles by Saran, A.

Basal Cell Carcinoma and Its Development

Insights from Radiation-Induced Tumors in Ptch1-Deficient Mice

¹ Biotechnology Unit and ² Radiation Protection Unit, ENEA-Ente per le Nuove Tecnologie, l’Energia e l’Ambiente, Centro Ricerche, Casaccia, Rome, Italy; ³ Institute of Human Genetics, University of Goettingen, Goettingen, Germany; and ⁴ Institute of Pathology, GSF-National Research Center for Environment and Health, Munich, Germany

Loss-of-function mutations in Patched (Ptch1) are implicated in constitutive activation of the Sonic hedgehog pathway in human basal cell carcinomas (BCCs), and inherited Ptch1 mutations underlie basal cell nevus syndrome in which a typical feature is multiple BCC occurring with greater incidence in portals of radiotherapy. Mice in which one copy of Ptch1 is inactivated show increased susceptibility to spontaneous tumor development and hypersensitivity to radiation-induced tumorigenesis, providing an ideal in vivo model to study the typical pathologies associated with basal cell nevus syndrome. We therefore examined BCC development in control and irradiated Ptch1^neo67/+ mice. We show that unirradiated mice develop putative BCC precursor lesions, i.e., basaloid hyperproliferation areas arising from both follicular and interfollicular epithelium, and that these lesions progress to nodular and infiltrative BCCs only in irradiated mice. Data of BCC incidence, multiplicity, and latency support the notion of epidermal hyperproliferations, nodular and infiltrative BCC-like tumors representing different stages of tumor development. This is additionally supported by the pattern of p53 protein expression observed in BCC subtypes and by the finding of retention of the normal remaining Ptch1 allele in all nodular, circumscribed BCCs analyzed compared with its constant loss in infiltrative BCCs. Our data suggest chronological tumor progression from basaloid hyperproliferations to nodular and then infiltrative BCC occurring in a stepwise fashion through the accumulation of sequential genetic alterations.

This article has been cited by other articles:

				A. Zibat, A. Uhmann, F. Nitzki, M. Wijgerde, A. Frommhold, T. Heller, V. Armstrong, L. Wojnowski, L. Quintanilla-Martinez, J. Reifenberger, et al. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts Carcinogenesis, June 1, 2009; 30(6): 918 - 926. [Abstract] [Full Text] [PDF]

				S. Grufferman, F. Ruymann, S. Ognjanovic, E. B. Erhardt, and H. M. Maurer Prenatal X-ray Exposure and Rhabdomyosarcoma in Children: A Report from the Children's Oncology Group Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1271 - 1276. [Abstract] [Full Text] [PDF]

				M. Mancuso, D. Gallo, and A. Saran Re: Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer Carcinogenesis, April 1, 2009; 30(4): 721 - 721. [Full Text] [PDF]

				M. Mancuso, D. Gallo, S. Leonardi, M. Pierdomenico, E. Pasquali, I. De Stefano, S. Rebessi, M. Tanori, G. Scambia, V. Di Majo, et al. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer Carcinogenesis, February 1, 2009; 30(2): 340 - 347. [Abstract] [Full Text] [PDF]

				M. Tanori, M. Mancuso, E. Pasquali, S. Leonardi, S. Rebessi, V. Di Majo, M.-N. Guilly, F. Giangaspero, V. Covelli, S. Pazzaglia, et al. PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma Carcinogenesis, October 1, 2008; 29(10): 1911 - 1919. [Abstract] [Full Text] [PDF]

				M. Mancuso, E. Pasquali, S. Leonardi, M. Tanori, S. Rebessi, V. Di Majo, S. Pazzaglia, M. P. Toni, M. Pimpinella, V. Covelli, et al. From the Cover: Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum PNAS, August 26, 2008; 105(34): 12445 - 12450. [Abstract] [Full Text] [PDF]

				S. Arad, E. Zattra, J. Hebert, E. H. Epstein Jr., D. A. Goukassian, and B. A. Gilchrest Topical Thymidine Dinucleotide Treatment Reduces Development of Ultraviolet-Induced Basal Cell Carcinoma in Ptch-1+/- Mice Am. J. Pathol., May 1, 2008; 172(5): 1248 - 1255. [Abstract] [Full Text] [PDF]

				T. Mizuno, S. Tokuoka, M. Kishikawa, E. Nakashima, K. Mabuchi, and K. S. Iwamoto Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations Carcinogenesis, November 1, 2006; 27(11): 2286 - 2294. [Abstract] [Full Text] [PDF]

				E. Nieuwenhuis, J. Motoyama, P. C. Barnfield, Y. Yoshikawa, X. Zhang, R. Mo, M. A. Crackower, and C.-c. Hui Mice with a Targeted Mutation of Patched2 Are Viable but Develop Alopecia and Epidermal Hyperplasia. Mol. Cell. Biol., September 1, 2006; 26(17): 6609 - 6622. [Abstract] [Full Text] [PDF]

				M. Kasper, H. Schnidar, G. W. Neill, M. Hanneder, S. Klingler, L. Blaas, C. Schmid, C. Hauser-Kronberger, G. Regl, M. P. Philpott, et al. Selective Modulation of Hedgehog/GLI Target Gene Expression by Epidermal Growth Factor Signaling in Human Keratinocytes. Mol. Cell. Biol., August 1, 2006; 26(16): 6283 - 6298. [Abstract] [Full Text] [PDF]

				Y. Lee, H. L. Miller, H. R. Russell, K. Boyd, T. Curran, and P. J. McKinnon Patched2 modulates tumorigenesis in patched1 heterozygous mice. Cancer Res., July 15, 2006; 66(14): 6964 - 6971. [Abstract] [Full Text] [PDF]

				M. Mancuso, S. Leonardi, M. Tanori, E. Pasquali, M. Pierdomenico, S. Rebessi, V. Di Majo, V. Covelli, S. Pazzaglia, and A. Saran Hair Cycle-Dependent Basal Cell Carcinoma Tumorigenesis in Ptc1neo67/+ Mice Exposed to Radiation. Cancer Res., July 1, 2006; 66(13): 6606 - 6614. [Abstract] [Full Text] [PDF]

				C. Adolphe, R. Hetherington, T. Ellis, and B. Wainwright Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression Cancer Res., February 15, 2006; 66(4): 2081 - 2088. [Abstract] [Full Text] [PDF]

				P. N. Schofield, J. B. L. Bard, J. Boniver, V. Covelli, P. Delvenne, M. Ellender, W. Engstrom, W. Goessner, M. Gruenberger, H. Hoefler, et al. Pathbase: a new reference resource and database for laboratory mouse pathology Radiat Prot Dosimetry, December 15, 2004; 112(4): 525 - 528. [Abstract] [Full Text] [PDF]

				P.-L. So, K. Lee, J. Hebert, P. Walker, Y. Lu, J. Hwang, L. Kopelovich, M. Athar, D. Bickers, M. Aszterbaum, et al. Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1+/- Mice Exposed to Ultraviolet or Ionizing Radiation Cancer Res., July 1, 2004; 64(13): 4385 - 4389. [Abstract] [Full Text] [PDF]

				S. Pazzaglia, M. Mancuso, M. Tanori, M. J. Atkinson, P. Merola, S. Rebessi, V. Di Majo, V. Covelli, H. Hahn, and A. Saran Modulation of Patched-Associated Susceptibility to Radiation Induced Tumorigenesis by Genetic Background Cancer Res., June 1, 2004; 64(11): 3798 - 3806. [Abstract] [Full Text] [PDF]